Reindel-Schwaighofer et al. compared serum ACE2 levels at two timepoints (0–3 days, and 9–11 days) between severe and non-severe COVID-19 patients and found that only the later sample correlated with disease severity [32]. Here, ACE2 is linked to COVID-19.